glp-1 weight loss guidelines New for therapy and obesity treatment | Samu Shiva, MD posted on the topic GLP-1 has changed the conversation

Appetite suppression without addressing underlying behavioral patterns or emotional regulation strategies leaves a substantial gap in care

Tirzepatide, followed by semaglutide, is the most likely to cause nausea and vomiting

Upon administration, GLP-1 medications enhance insulin secretion, inhibit glucagon release, and slow gastric emptying

The central research question guiding this analysis is: Do GLP-1 agonists represent a genuine game-changing breakthrough in obesity treatment, or are they an overhyped intervention with significant practical limitations that may limit their real-world impact

Follow along on Instagram (@weightwatchers), and TikTok (@weightwatchers), for more details

Log injectionsincluding the medication, dose, and siteas well as side effects so you can better understand your body and what helps you feel your best